| Unique ID issued by UMIN | UMIN000055343 |
|---|---|
| Receipt number | R000063248 |
| Scientific Title | The effects of test products on cutaneous blood flow and autonomic nervous system: Open-label study |
| Date of disclosure of the study information | 2024/08/27 |
| Last modified on | 2024/12/02 18:47:12 |
The effects of test products on cutaneous blood flow and autonomic nervous system
The effects of test products on cutaneous blood flow and autonomic nervous system
The effects of test products on cutaneous blood flow and autonomic nervous system: Open-label study
The effects of test products on cutaneous blood flow and autonomic nervous system: Open-label study
| Japan |
Healthy adults
| Adult |
Others
NO
Evaluate the effects of test products on cutaneous blood flow and autonomic nervous system
Efficacy
Skin blood flow rate
Autonomic nervous system
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
| Other |
using test products
| 40 | years-old | <= |
| 59 | years-old | >= |
Male and Female
(1)Subjects of men and women aged 40 to 59
(2) Subjects who received sufficient explanation about the purpose and content of the test, had the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the test in writing.
(1) Subjects with heart, liver, and kidney diseases (including complications of other diseases)
(2) Subjects with a history of cardiovascular disease
(3) Subjects with diabetes
(4) Subjects with diseases currently being treated
(5) Subjects who are allergic to food and drugs
(6) Female subjects wishing to become pregnant while participating in this study, pregnant (including those who may be pregnant) or lactating female subjects
(7) Subjects who are in the hospital or being treated with drugs or Chinese herbal medicine for some disease (can be used additionally)
(8) Subjects who play intense sports and subjects who are on a diet
(9) Subjects with extremely irregular eating habits
(10) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period
(11) Subjects who drink more than 40g of avarage daily pure alcohol
(12) Subjects who smoke an average of 21 or more cigarettes a day
(13) Subjects who are participating in or will participate in other clinical trials at the start of this study.
(14) Other subjects judged by the investigator or the investigator to be inappropriate for the examination
3
| 1st name | Naoki |
| Middle name | |
| Last name | Miura |
Miura Clinic, Medical Corporation Kanonkai
Internal medicine
5300044
Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka
06-6135-5200
info@miura-cl.jp
| 1st name | Makoto |
| Middle name | |
| Last name | Terashima |
Oneness Support Co., Ltd.
Clinical Trial Division
5300044
Higashitenma building 6F, 1-7-17, Higashitenma, Kita-ku, Osaka
06-4801-8917
mterashima@oneness-sup.co.jp
Miura Clinic, Medical Corporation Kanonkai
Aleap Co., Ltd.
Profit organization
The Ethics Committee of Miura Clinic, Medical Corporaion Kanonkai
Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka
06-6135-5200
mterashima@miura-cl.jp
NO
医療法人花音会みうらクリニック(大阪府)
| 2024 | Year | 08 | Month | 27 | Day |
Unpublished
Completed
| 2024 | Year | 08 | Month | 05 | Day |
| 2024 | Year | 08 | Month | 08 | Day |
| 2024 | Year | 08 | Month | 27 | Day |
| 2024 | Year | 09 | Month | 30 | Day |
| 2024 | Year | 08 | Month | 27 | Day |
| 2024 | Year | 12 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063248